1162 related articles for article (PubMed ID: 1531321)
21. T cell regulation of human B cell proliferation and differentiation. Regulatory influences of CD45R+ and CD45R- T4 cell subsets.
Hirohata S; Lipsky PE
J Immunol; 1989 Apr; 142(8):2597-607. PubMed ID: 2564858
[TBL] [Abstract][Full Text] [Related]
22. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules.
Ernst DN; Weigle WO; McQuitty DN; Rothermel AL; Hobbs MV
J Immunol; 1989 Mar; 142(5):1413-21. PubMed ID: 2521878
[TBL] [Abstract][Full Text] [Related]
24. Concomitant administration of hapten and IL-2-toxin (DAB486-IL-2) results in specific deletion of antigen-activated T cell clones.
Bastos MG; Pankewycz O; Rubin-Kelley VE; Murphy JR; Strom TB
J Immunol; 1990 Dec; 145(11):3535-9. PubMed ID: 2147194
[TBL] [Abstract][Full Text] [Related]
25. Regulatory function for murine intraepithelial lymphocytes. Two subsets of CD3+, T cell receptor-1+ intraepithelial lymphocyte T cells abrogate oral tolerance.
Fujihashi K; Taguchi T; McGhee JR; Eldridge JH; Bruce MG; Green DR; Singh B; Kiyono H
J Immunol; 1990 Oct; 145(7):2010-9. PubMed ID: 1975820
[TBL] [Abstract][Full Text] [Related]
26. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
Matsushima GK; Stohlman SA
J Immunol; 1991 May; 146(10):3322-31. PubMed ID: 1673982
[TBL] [Abstract][Full Text] [Related]
27. Minimal growth requirements of mature T lymphocytes: interleukin (IL)-1 and IL-6 increase growth rate but not plating efficiency of CD4 cells stimulated with anti-CD3 and IL-2.
Soldaini E; MacDonald HR; Nabholz M
Eur J Immunol; 1992 Jul; 22(7):1707-11. PubMed ID: 1352498
[TBL] [Abstract][Full Text] [Related]
28. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Smyth MJ; Norihisa Y; Ortaldo JR
J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
[TBL] [Abstract][Full Text] [Related]
29. Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity.
Chou T; Chang AE; Shu SY
J Immunol; 1988 Apr; 140(7):2453-61. PubMed ID: 2450925
[TBL] [Abstract][Full Text] [Related]
30. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
31. Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 co-stimulation.
Seeley BM; Barthel SW; To WC; Kjaergaard J; Shu S; Plautz GE
Otolaryngol Head Neck Surg; 2001 Apr; 124(4):436-41. PubMed ID: 11283503
[TBL] [Abstract][Full Text] [Related]
32. In vivo antitumor activity of anti-CD3-induced activated killer cells.
Yun YS; Hargrove ME; Ting CC
Cancer Res; 1989 Sep; 49(17):4770-4. PubMed ID: 2527087
[TBL] [Abstract][Full Text] [Related]
33. Intact antigen receptor-mediated generation of inositol phosphates and increased intracellular calcium in CD4 CD8 T lymphocytes from MRL lpr mice.
Budd RC; Winslow G; Inokuchi S; Imboden JB
J Immunol; 1990 Nov; 145(9):2862-72. PubMed ID: 1976707
[TBL] [Abstract][Full Text] [Related]
34. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy of Th1 and Th2 L-selectin--CD4+ tumor-reactive T cells.
To WC; Seeley BM; Barthel SW; Shu S
Laryngoscope; 2000 Oct; 110(10 Pt 1):1648-54. PubMed ID: 11037819
[TBL] [Abstract][Full Text] [Related]
36. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
[TBL] [Abstract][Full Text] [Related]
37. MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response.
Leite-de-Moraes MC; Herbelin A; Machavoine F; Vicari A; Gombert JM; Papiernik M; Dy M
J Immunol; 1995 Nov; 155(10):4544-50. PubMed ID: 7594451
[TBL] [Abstract][Full Text] [Related]
38. Anti-CD3 antibodies induce T cells from unprimed animals to secrete IL-4 both in vitro and in vivo.
Flamand V; Abramowicz D; Goldman M; Biernaux C; Huez G; Urbain J; Moser M; Leo O
J Immunol; 1990 Apr; 144(8):2875-82. PubMed ID: 1969874
[TBL] [Abstract][Full Text] [Related]
39. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
[TBL] [Abstract][Full Text] [Related]
40. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]